Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain
Authors:
- Carly A. WattCWCarly A. Watt
- Catherine LedentCLCatherine Ledent
- Areles MollemanAMAreles Molleman
- Rüdiger U. HasenöhrlRHRüdiger U. Hasenöhrl
- 1 June 2009
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 200 (1) , 60-67
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to PsychostimulantsJournal of Neuroscience, 2007
- Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related RisksCirculation, 2006
- Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404Neuropsychopharmacology, 2006
- Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysisProceedings of the National Academy of Sciences, 2005
- Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptorsProceedings of the National Academy of Sciences, 2005
- The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout miceLife Sciences, 2004
- Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinolPsychopharmacology, 2002
- Neurobiological mechanisms by which nicotine mediates different types of anxietyEuropean Journal of Pharmacology, 2000
- In-Vitro and In-Vivo Action of CannabinoidsNeurochemical Research, 1999
- Ethopharmacological analysis of rat behavior on the elevated plus-mazePharmacology Biochemistry and Behavior, 1994